Lorazepam Tablet
Product Images NDC 61919-062

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 61919-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

062 (062 60)

062 (062 60)
Lorazepam C-IV 0.5 mg yellow pharmaceutical label showing a bottle containing 60 tablets. The label states the product is a generic for Ativan, with each tablet containing Lorazepam USP 0.5 mg. Distributed by Direct_Rx in Alpharetta, GA. The NDC number 61919-062-60 is visible along with drug warnings about drowsiness and alcohol use.*
FDA Label Image

61919 062 02

61919 062 02
Lorazepam C-IV 0.5 mg tablet packaging label showing 2 tablets per package, generic for Ativan. The label includes the NDC 61919-062-02, batch number 07JA2219, expiration date 08/31/24, and is packaged by Direct Rx in Dawsonville, GA. Additional regulatory and manufacturing information is present on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.